Silvia Romano

Pubblicazioni

Titolo Pubblicato in Anno
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register NEUROLOGICAL SCIENCES 2022
A clinical and epidemiological prevalence study on Friedreich’s Ataxia in Latium, Italy NEUROEPIDEMIOLOGY 2022
Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome SCIENTIFIC REPORTS 2022
Circulating U13 small nucleolar RNA as a candidate biomarker for Huntington's disease biorXiv 2022
CADASIL or MS? Consider “Red Flags” but Avoid a Misdiagnosis: Case Series of a Concomitant Diagnosis ARCHIVES OF CLINICAL AND MEDICAL CASE REPORTS 2022
Cognitive Reserve in Early Manifest Huntington Disease Patients: Leisure Time Is Associated with Lower Cognitive and Functional Impairment JOURNAL OF PERSONALIZED MEDICINE 2022
Huntington's disease age at motor onset is modified by the tandem hexamer repeat in TCERG1 NPJ GENOMIC MEDICINE 2022
Exome sequencing of individuals with Huntington's disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset NATURE NEUROSCIENCE 2022
Circulating U13 small nucleolar RNA as a candidate biomarker for Huntington's disease: A Pilot Study INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
Machine Learning use for prognostic purposes in Multiple Sclerosis LIFE 2021
The neurobiological underpinning of the social cognition impairments in patients with spinocerebellar ataxia type 2 CORTEX 2021
Circulating hsa-miR-323b-3p in Huntington's Disease. A Pilot Study FRONTIERS IN NEUROLOGY 2021
Mait cells and microbiota in multiple sclerosis and other autoimmune diseases MICROORGANISMS 2021
A case of double standard. Sex differences in multiple sclerosis risk factors INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2021
Cognitive and behavioral associated changes in manifest Huntington disease. A retrospective cross-sectional study BRAIN AND BEHAVIOR 2021
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration JOURNAL OF NEUROLOGY 2021
Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing–Remitting Multiple Sclerosis Treated With Dimethylfumarate FRONTIERS IN NEUROLOGY 2021
Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease NEUROLOGY 2021
Enrichment analysis of GWAS data in autoimmunity delineates the multiple sclerosis-Epstein Barr virus association biorXiv 2021
Disentangling the molecular mechanisms of multiple sclerosis: the contribution of twin studies NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS 2020

ERC

  • LS5_11

Interessi di ricerca

  • Diagnosi, terapia e classificazione fenotipica delle atassie cerebellari ereditarie
  • Diagnosi, terapia e classificazione fenotipica idelle paraparesi spastiche ereditarie
  • Diagnosi, terapia e classificazione fenotipica idelle malattie monogeniche dei piccoli vasi (CADASIL, CARASIL)
  • Ricerca di biomarcatori circolanti nella Malattia di Huntington

 

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma